Kathleen L Grady, Mary Amanda Dew, Francis D Pagani, John A Spertus, Eileen Hsich, Melana Yuzefpolskaya, Brent Lampert, James K Kirklin, Michael Petty, Andrew Kao, Clyde Yancy, Justin Hartupee, Salpy V Pamboukian, Maryl Johnson, Margaret Murray, Tingqing Wu, Adin-Cristian Andrei
BACKGROUND: The quality-adjusted life year (QALY) measures disease burden and treatment, combining overall survival and health-related quality of life (HRQOL). We estimated QALYs in three groups of older patients (60-80 years) with heart failure (HF) who underwent heart transplantation (HT, with pre-transplant mechanical circulatory support [HT MCS] or HT without pre-transplant MCS [HT Non-MCS]) or long-term MCS (destination therapy). We also identified factors associated with gains in QALYs through 24 months follow-up...
May 16, 2024: Journal of Heart and Lung Transplantation